MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CGTX — Cognition Therapeutics, Inc. Common Stock
NasdaqCognition Therapeutics, Inc. Common Stock
$0.93
+0.03(+3.80%)
- O
- 0.92
- H
- 0.93
- L
- 0.90
- V
- 299.68K
⏱️ End-of-day dataAs of Oct 2, 2026
CGTX — Latest News & Headlines
3 StoriesAn experimental drug slowed the progression of hallucinations and delusions by 89% vs. placebo. - Stock Titan
An experimental drug slowed the progression of hallucinations and delusions by 89% vs. placebo. Stock Titan
Cognition Therapeutics Schedules FDA Type C Meeting to Discuss Phase 3 Trial Endpoint for Zervimesine in Dementia with Lewy Bodies - Quiver Quantitative
Cognition Therapeutics Schedules FDA Type C Meeting to Discuss Phase 3 Trial Endpoint for Zervimesine in Dementia with Lewy Bodies Quiver Quantitative
TOYO Stock Crashes More Than 37%, Cracks Below 200-DMA For The First Time In Nearly 13 Months – Retail Calls The Selloff An ‘Overkill’ - Stocktwits
TOYO Stock Crashes More Than 37%, Cracks Below 200-DMA For The First Time In Nearly 13 Months – Retail Calls The Selloff An ‘Overkill’ Stocktwits